Keywords: Cambrex, Zenara Pharma, Nicotine replacement, APIs, India

Cambrex Corp acquires 51% stake in India’s Zenara for $20 million

Article | 04 November 2010

Print This

New Jersey, USA-based drugmaker Cambrex Corp (NYSE: CBM) says that it acquired a 51% stake in Zenara Pharma, a Hyderabad, India ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in